Table II.
Association between CHKA expression and clinicopathological characteristics of lung adenocarcinoma patients.
| CHKA expression, N (%) | ||||
|---|---|---|---|---|
| Characteristics | N | Low N=59 | High N=60 | P-value |
| Age | 0.650 | |||
| ≤65 years | 63 | 30 (47.6) | 33 (52.4) | |
| >65 years | 56 | 29 (51.8) | 27 (48.2) | |
| Gender | 0.230 | |||
| Male | 61 | 27 (44.3) | 34 (55.7) | |
| Female | 58 | 32 (55.2) | 26 (44.8) | |
| Smoking | 0.770 | |||
| Yes | 69 | 35 (50.7) | 34 (49.3) | |
| No | 50 | 24 (48.0) | 26 (52.0) | |
| Tumor diametera | 0.020 | |||
| ≤3 cm | 54 | 33 (61.1) | 21 (38.9) | |
| >3 cm | 65 | 26 (40.0) | 39 (60.0) | |
| Lymph metastasis | 0.530 | |||
| Yes | 72 | 34 (47.2) | 38 (52.8) | |
| No | 47 | 25 (53.2) | 22 (46.8) | |
| Differentiationa | 0.001 | |||
| Well | 64 | 43 (67.2) | 21 (32.8) | |
| Poor | 55 | 16 (29.1) | 39 (70.9) | |
| TNM stagea | 0.050 | |||
| T1/2 | 66 | 38 (57.6) | 28 (42.4) | |
| T3/4 | 53 | 21 (39.6) | 32 (60.4) | |
a
Significant parameters. TNM, tumor-node-metastasis; CHKA, choline kinase α